OROVY yields 10.93% · JNJ yields 2.13%● Live data
📍 OROVY pulled ahead of the other in Year 1
Combined, OROVY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OROVY + JNJ for your $10,000?
Orient Overseas (International) Limited, an investment holding company, provides container transport and logistics services in Asia, Europe, Australia, North America, and internationally. The company offers supply-chain management and distribution services; and containerised shipping services in various trade lanes comprising Trans-Pacific, Trans-Atlantic, Asia/Europe, Asia/Australia, and Intra-Asia trades. It is also involved in equipment owning and leasing, container depot and warehousing, portfolio investment, terminal operating, ship owning, cargo consolidation and forwarding, liner and freight agency, property owning, and ship management businesses; providing corporate and trucking services; and operating vessels. In addition, the company offers AI and blockchain digital data on network applications, and platform design services, as well as technology and consulting services. The company is based in Wan Chai, Hong Kong. Orient Overseas (International) Limited is a subsidiary of Faulkner Global Holdings Limited.
Full OROVY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.